We have identified several SUMOylation pathways such as ERK5 SUMOylation, p53 SUMOylation, and MK2 SUMOylation that influence EC inflammation and EC apoptosis, and these pathways have potential relevance to early events of atherosclerosis. This evidence concerns the gene MAPKAPK2 and atherosclerosis.